Market closedNon-fractional
Maravai LifeSciences/MRVI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Maravai LifeSciences
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Ticker
MRVI
Sector
Healthcare
Trading on
NASDAQ
Industry
Life Sciences Tools and Services
Headquarters
San Diego, United States
Employees
570
Website
www.maravai.com
MRVI Metrics
BasicAdvanced
$1.1B
Market cap
-
P/E ratio
-$0.99
EPS
0.02
Beta
-
Dividend rate
Price and volume
Market cap
$1.1B
Beta
0.02
Financial strength
Current ratio
11.316
Quick ratio
10.186
Long term debt to equity
77.906
Total debt to equity
77.349
Interest coverage (TTM)
-1.05%
Management effectiveness
Return on assets (TTM)
-1.56%
Return on equity (TTM)
-19.04%
Valuation
Price to revenue (TTM)
4.1
Price to book
2.75
Price to tangible book (TTM)
-8.71
Price to free cash flow (TTM)
-36.648
Growth
Revenue change (TTM)
-61.81%
Earnings per share change (TTM)
-185.20%
3-year revenue growth (CAGR)
-10.42%
3-year earnings per share growth (CAGR)
11.95%
What the Analysts think about MRVI
Analyst Ratings
Majority rating from 13 analysts.
MRVI Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$64M
-13.50%
Net income
-$12M
-88.67%
Profit margin
-18.72%
-86.90%
MRVI Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-
-$0.01
$0.01
-$0.02
-
Expected
$0.01
$0.01
-$0.01
-$0.03
$0.00
Surprise
-
-257.13%
-184.62%
-21.43%
-
MRVI News
AllArticlesVideos
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
GlobeNewsWire·2 weeks ago
Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report
GlobeNewsWire·3 weeks ago
Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics
Accesswire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Maravai LifeSciences stock?
Maravai LifeSciences (MRVI) has a market cap of $1.1B as of July 27, 2024.
What is the P/E ratio for Maravai LifeSciences stock?
The price to earnings (P/E) ratio for Maravai LifeSciences (MRVI) stock is 0 as of July 27, 2024.
Does Maravai LifeSciences stock pay dividends?
No, Maravai LifeSciences (MRVI) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Maravai LifeSciences dividend payment date?
Maravai LifeSciences (MRVI) stock does not pay dividends to its shareholders.
What is the beta indicator for Maravai LifeSciences?
Maravai LifeSciences (MRVI) has a beta rating of 0.02. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Maravai LifeSciences stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.